OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $38,000 | -81.6% | 22,293 | -77.2% | 0.00% | – |
Q3 2015 | $206,000 | -82.6% | 97,735 | -59.2% | 0.00% | -100.0% |
Q2 2015 | $1,186,000 | -81.6% | 239,648 | -70.9% | 0.00% | -80.0% |
Q1 2015 | $6,441,000 | +44.3% | 822,562 | +11.6% | 0.01% | +66.7% |
Q4 2014 | $4,465,000 | +3.0% | 736,821 | -27.6% | 0.01% | 0.0% |
Q3 2014 | $4,334,000 | -17.7% | 1,017,360 | +19.4% | 0.01% | -14.3% |
Q2 2014 | $5,267,000 | +12.4% | 852,313 | +18.2% | 0.01% | 0.0% |
Q1 2014 | $4,687,000 | -46.2% | 721,088 | -53.4% | 0.01% | -41.7% |
Q4 2013 | $8,716,000 | +1.5% | 1,548,176 | +10.7% | 0.01% | -14.3% |
Q3 2013 | $8,589,000 | +5.3% | 1,398,910 | +0.3% | 0.01% | -6.7% |
Q2 2013 | $8,156,000 | – | 1,394,277 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |